ADBAC/BKC in PT2 - Information on Approval Status

On 2nd of December 2021, the ECHA Biocidal Products Committee (BPC) recommended the approval of ABDAC/BKC and adopted the BPC opinion for PT2 by simple majority. Two Member States (Germany and Finland) raised their concerns about unacceptable risk for environment, mainly for the soil compartment.

As the concerns could not be solved at the 76th meeting of the Standing Committee of Biocidal products (SCBP) on 24th June 2022, ECHA organized a dedicated meeting with the eCA, the concerned Member States and the Commission services on 23rd August 2022 to resolve the reservations of the concerned Member States.

It became clear during the 77th meeting of the SCBP that further discussions and assessment are needed to be able to clarify whether the exposure of the active substance to soil compartment is resulting in an acceptable risk or not.

Therefore, ECHA is requested to revise its opinion on ADBAC/BKC for PT2 considering the information available in the application for approval of the active substance, discussions and arguments expressed during the various expert and regulatory meetings (BPC Environment Working Group, BPC plenary, the Standing Committee meeting, and the ad-hoc meeting of 23 August 2022), as well as the additional arguments that may be put forward during the additional discussions it will organise.

ECHA is requested to provide a revised assessment report and a revised opinion.

As the opinion shall be adopted by 30th June 2023 at the latest, the approval of ADBAC/BKC for PT2 can be expected in July 2025.

Sources:

Mandate requesting ECHA opinions under Article 75(1)(g) of the BPR "Re-assessing the risk on the environment (soil compartment) posed by ADBAC/BKC from use in biocidal products of PT2"